• Kanaph Therapeutics Closes 21M USD Series B Funding prnasia
    October 15, 2020
    Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of 21M USD in South Korea.
  • EdiGene raises $15 M in Series B funding biospectrumasia
    April 11, 2019
    EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic ……
PharmaSources Customer Service